M14-360
ClinicalTrials.gov NCT02412371
Research payments
$260,317
Through program year 2020, $260,317 in research payments was reported against M14-360, across 68 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT02412371
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $206,177 | 39 |
| 2019 | Research | $54,140 | 29 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Michael Guarino Newark, DE Named on 25 payments
- Joseph Salama Durham, NC Named on 6 payments
- Jeffrey Bogart Syracuse, NY Named on 5 payments
- Lyudmila Bazhenova San Diego, CA Named on 5 payments
- Roger Keresztes Stony Brook, NY Named on 3 payments
- David Kozono Boston, MA Named on 3 payments
- Ravi Salgia Duarte, CA Named on 3 payments
- Thomas Stinchcombe Chapel Hill, NC Named on 3 payments
- Estelamari Rodriguez Miami, FL Named on 3 payments
- Thomas Dipetrillo Providence, RI Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.